This special episode of the "Nervennahrung" podcast introduces Professor Tobias Ruck as the new co-host, succeeding Professor Sven Meuth. Host Matthias Meurer interviews Ruck to familiarize the audience with his background, expertise, and vision for the future of neurology. Ruck details his career path from Würzburg to his current position as Director of Neurology in Bochum, highlighting his close collaboration with his predecessor. His clinical and research focus lies in neuromuscular diseases, including myasthenia gravis, myositis, and hereditary neuropathies, with a particular emphasis on immunology and emerging gene therapies. The conversation also explores broader trends in neurology, such as the impact of artificial intelligence, the challenge of increasing specialization, and the significance of the recent approval of Lecanemab for Alzheimer's disease.
Introducing Professor Tobias Ruck: The New Co-Host of the Nervennahrung Podcast
00:00:12 Announcement of Change: Host Matthias Meurer announces that Professor Sven Meuth is stepping down as co-host due to his new responsibilities. He warmly welcomes his successor, Professor Tobias Ruck.
00:00:58 Meet the New Host: Professor Tobias Ruck is the Director of Neurology at Bergmannsheil in Bochum. He previously served as Sven Meuth's deputy at the University Hospital Düsseldorf, making him a natural successor for the podcast.
00:02:59 Shared Beginnings and Career Path: Ruck discusses his academic journey, which began in Würzburg, where he developed a keen interest in neuroimmunology. He later followed his mentors to Münster and worked closely with Sven Meuth in Düsseldorf, developing a complementary expertise focused on immunology and the peripheral nervous system.
00:05:40 Clinical and Research Focus: Ruck’s primary clinical and research interests are in neuromuscular diseases, particularly myasthenia gravis, myositis, inflammatory neuropathies (like CIDP), and hereditary neuromuscular disorders.
00:06:15 The Revolution in Gene Therapy: He expresses his excitement about the "revolutions" happening in neurology, especially the development of vector-based gene therapies for previously untreatable hereditary conditions like Duchenne muscular dystrophy and certain neuropathies.
00:09:47 The Future of Neurology: Ruck shares his perspective on the future of the field, predicting further specialization but stressing the importance of maintaining a holistic diagnostic approach. He is optimistic that artificial intelligence (AI) will aid in diagnostics and monitoring, freeing up clinicians' time for direct patient care.
00:11:47 A Milestone in Alzheimer's Therapy: The hosts discuss the recent approval of Lecanemab, viewing it as a crucial first step for Alzheimer's therapy, even with modest effects. They draw parallels to the early days of MS treatment and anticipate the challenges of managing patient expectations and logistics.
00:13:52 Future Podcast Direction: With Ruck's expertise, the podcast is expected to delve deeper into topics concerning the peripheral nervous system, neuroimmunology, and gene therapy, while continuing to cover major areas like MS and neurodegeneration.
00:15:07 A Glimpse into Personal Life: Outside of neurology, Ruck is a father to two young children and enjoys playing tennis and attending cultural events in his free time.
00:16:25 Looking Forward: Both hosts conclude by expressing their enthusiasm for their future collaboration, promising to continue bringing listeners engaging discussions on the most interesting topics in neurology with leading experts.